Literature DB >> 15250182

Dyslexic students have more everyday cognitive lapses.

James H Smith-Spark1, Angela J Fawcett, Roderick I Nicolson, John E Fisk.   

Abstract

There is a dearth of information about the everyday performance difficulties of adult dyslexic people. This study investigates the empirical support for anecdotal reports of increased vulnerability to distraction in dyslexia, using the self-report Cognitive Failures Questionnaire (CFQ). Two groups of university students, a dyslexic group and a non-dyslexic control group, were asked to complete the CFQ. The dyslexic group reported a higher frequency of everyday lapses in cognition, scoring significantly higher on a number of CFQ items. Representative problems include distractibility, over-focusing (so that relevant peripheral information is missed), and word-finding difficulties. A similar measure administered to close friends of dyslexic people, the CFQ-for-others, yielded results consistent with those of the CFQ, with major findings being that their friends considered them to be more disorganised, more distractible, and more absent-minded than normal. The results indicate clearly the continuing effects of dyslexia on cognition in adulthood and demonstrate that dyslexic impairments are not limited to "artificial" laboratory tasks or even literacy tasks but, instead, pervade everyday life.

Entities:  

Mesh:

Year:  2004        PMID: 15250182     DOI: 10.1080/09658210244000450

Source DB:  PubMed          Journal:  Memory        ISSN: 0965-8211


  2 in total

1.  Atomoxetine improved attention in children and adolescents with attention-deficit/hyperactivity disorder and dyslexia in a 16 week, acute, randomized, double-blind trial.

Authors:  Linda Wietecha; David Williams; Sally Shaywitz; Bennett Shaywitz; Stephen R Hooper; Sharon B Wigal; David Dunn; Keith McBurnett
Journal:  J Child Adolesc Psychopharmacol       Date:  2013-11-09       Impact factor: 2.576

2.  Brazilian version of the Cognitive Failures Questionnaire (CFQ): cross-cultural adaptation and evidence of validity and reliability.

Authors:  Jonas J de Paula; Danielle S Costa; Débora M de Miranda; Marco A Romano-Silva
Journal:  Braz J Psychiatry       Date:  2017-12-11       Impact factor: 2.697

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.